| Literature DB >> 26951538 |
Anna P Sokolenko1,2, Nikita M Volkov3, Elena V Preobrazhenskaya1,2, Evgeny N Suspitsin1,2, Aigul R Garifullina1, Alexandr V Ivantsov1,2, Alexandr V Togo1,2, Evgeny N Imyanitov4,5,6,7.
Abstract
BRCA1 L1705P (c.5114T>C) has been classified in the NCBI SNP database as the variant with uncertain significance and is absent in major BRCA1 databases. BRCA1 W1837X (c.5511G>A) results in a loss of only last 27 residues of BRCA1 protein, thus its pathogenic role still requires a confirmation. This report describes two breast cancer (BC) patients carrying BRCA1 L1705P and W1837X germ-line mutations, respectively. Significant evidence for BC-predisposing impact of the mentioned mutations have been obtained: (1) both index cases presented with the triple-negative receptor status of BC disease; (2) complete segregation with BRCA1-related cancers was observed in the families of these patients; (3) somatic loss of the remaining (wild-type) BRCA1 allele was detected in tumor tissues of the affected women. The results of this study have to be taken into account while providing genetic counseling to cancer patients and while considering the use of BRCA1-specific therapeutic compounds for BC treatment.Entities:
Keywords: BRCA1; Breast cancer; Hereditary predisposition; Mutation; PARP inhibitors
Mesh：
Substances：
Year: 2016 PMID： 26951538 DOI： 10.1007/s11033-016-3968-0
Source DB: PubMed Journal: Mol Biol Rep ISSN： 0301-4851 Impact factor: 2.316